Insider trading

Period: 120 months Stock: WTW Plan: Discretionary × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

17 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

17 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

17 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

17 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
17 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
17 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

17 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
10 Aug 2026
Faber Alexis Chief Operating Officer
Sold at will
$250.17K 730 at 342.70
6.4%
Not planned
6 May 2026
Clarke Lucy President of Risk & Broking
Bought
$499.34K 1,896 at 263.37
9.1%
4 May 2026
Hess Carl Aaron Chief Executive Officer
Bought
$510.16K 2,000 at 255.08
1.7%
First buy on file
3 Mar 2026
Furman Matthew General Counsel
Sold at will
$912.01K 3,000 at 304.00
7.3%
Not planned
13 Feb 2026
Clarke Lucy President of Risk & Broking
Bought
$996.93K 3,500 at 284.84
22.2%
First buy on file
12 Feb 2026
Bought
$67.21K 241 at 278.86
10.6%
First buy on file
3 Mar 2025
Gebauer Julie Jarecke Pres.-Health, Wealth & Career
Sold at will
$547.40K 1,616 at 338.74
2.2%
Not planned
28 Feb 2025
Gebauer Julie Jarecke Pres.-Health, Wealth & Career
Sold at will
$1.14M 3,384 at 335.77
4.3%
Not planned
1 Mar 2024
Krasner Andrew Jay Chief Financial Officer · indirect
Sold at will
$299.35K 1,100 at 272.13
20.9%
Not planned
20 Feb 2024
Gebauer Julie Jarecke Head of Health, Wealth &Career
Sold at will
$1.38M 5,000 at 276.03
6.8%
Not planned
8 Feb 2024
Garrard Adam Head of Risk & Broking
Sold at will
$1.46M 5,400 at 270.41
32.4%
Not planned
9 Nov 2023
Thomson-Hall Pamela Head of International
Sold at will
$78.83K 330 at 238.87
9.0%
Not planned
3 Jul 2023
Gebauer Julie Jarecke Head of Health, Wealth &Career
Sold at will 3×
$463.38K 2,000 at 231.69
2.6%
Not planned
7 Jun 2023
Pullum Anne Head of Europe
Sold at will
$1.12M 5,000 at 224.45
28.1%
Not planned
1 Jun 2023
Gebauer Julie Jarecke Head of Health, Wealth &Career
Sold at will
$545.87K 2,500 at 218.35
3.1%
Not planned
1 May 2023
Gebauer Julie Jarecke Head of Health, Wealth &Career
Sold at will
$578.59K 2,500 at 231.44
3.0%
Not planned
3 Apr 2023
Gebauer Julie Jarecke Head of Health, Wealth &Career
Sold at will
$580.94K 2,500 at 232.38
2.9%
Not planned
Showing 1–17 of 17.